Guidelines for Clinical and Programmatic Management of TB, TB/HIV, DR-TB and Leprosy in Ethiopia

dc.contributor.author	Ministry of Health
dc.date.accessioned	2022-10-18T05:36:47Z
dc.date.available	2022-10-18T05:36:47Z
dc.date.issued	2022
dc.identifier.uri	http://repository.iphce.org/xmlui/handle/123456789/1662
dc.description.abstract	Tuberculosis (TB) is a major global public health problem. About a quarter of the world’s population is infected with Mycobacterium Tuberculosis and thus at risk of developing TB disease. TB is among the top 10 causes of death globally. According to 2020 WHO Global TB Report, an estimated 10.0 million people fell ill with TB, 1.2 million TB deaths among HIV-negative people and an additional 208,000 deaths among PLHIV in 2019. Drugresistant TB continues to be a global public health threat with 3.4% of new TB cases and 18% of previously treated cases having multidrug resistant TB or rifampicin-resistant TB (MDR/RR-TB).	en_US
dc.language.iso	en_US	en_US
dc.publisher	Ministry of health - Ethiopia	en_US
dc.subject	TB	en_US
dc.title	Guidelines for Clinical and Programmatic Management of TB, TB/HIV, DR-TB and Leprosy in Ethiopia	en_US
dc.type	Learning Object	en_US